首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1489241

全球阿苯達唑獸醫市場研究報告 - 2024 年至 2032 年行業分析、規模、佔有率、成長、趨勢和預測

Global Albendazole Veterinary Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年05月01日 | 出版商:

Value Market Research | 英文 171 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球阿苯達唑獸藥市場需求預計將從2023年的1.9078億美元達到近3.5759億美元的市場規模，2024-2050年研究期間複合年成長率為7.23%。

阿苯達唑是一種驅蟲藥，用於獸醫治療動物（包括牲畜和寵物）的寄生蟲感染。它對各種體內寄生蟲有效，如蛔蟲、絛蟲和吸蟲。口服阿苯達唑會抑制寄生蟲的能量代謝，導致其死亡。它通常用於改善動物健康和農業生產力以及治療寵物。獸醫使用阿苯達唑必須謹慎管理，以防止抗藥性並確保食品安全。

市場動態

家畜和伴侶動物寄生蟲感染的廣泛流行推動了阿苯達唑獸醫市場的發展。為了滿足對肉類、牛奶和其他動物產品不斷成長的需求，畜牧業對改善動物健康和生產力的日益關注顯著促進了市場成長。此外，寵物主人對定期驅蟲和預防人畜共患病的健康益處的認知不斷提高，推動了阿苯達唑在伴侶動物中的使用。促進使用獸藥以確保動物福利和食品安全的政府法規和指南進一步支持阿苯達唑獸藥市場的成長。獸醫技術的進步導致了更有效和方便用戶使用的阿苯達唑製劑的開發，也有助於增加採用。獸醫實踐中預防性保健的日益成長的趨勢強調定期寄生蟲控制，強調了對阿苯達唑等有效驅蟲藥的需求。此外，全球牲畜數量的不斷增加和農業實踐的集約化需要常規使用抗寄生蟲治療，從而推動市場成長。隨著人們對動物健康的認知和重視程度不斷提高，對阿苯達唑獸藥產品的需求預計將保持強勁，從而促進市場擴張。然而，嚴格的監管批准和替代療法的出現可能會挑戰未來幾年的市場成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對阿苯達唑獸藥全球市場的每個細分市場進行了包容性評估。阿苯達唑獸醫行業的成長和趨勢為本研究提供了整體方法。

市場區隔

阿苯達唑獸醫市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助戰略家確定相應產品或服務的目標人口統計數據以及即將到來的機會。

按動物分類

豬
牛
其他（駱駝等）

按形式

平板電腦
膠囊
其他（糖漿等）

按最終用戶

獸醫診所
獸醫院
農場
其他（研究所等）

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲阿苯達唑獸醫市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。阿苯達唑獸藥市場的主要參與者包括GSK Plc、Sequent Scientific Ltd.、Zoetis Inc.、AdvaCare Pharma、廣東天寶生物製藥有限公司、漢中未來生物科技有限公司、河北華邦生物科技有限公司、Salius製藥列兵。有限公司、Supharma Chem、Fredun Pharmaceuticals。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：阿苯達唑獸藥公司的競爭格局

阿苯達唑獸藥市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

頂級公司市佔率分析
市場集中度
GSK Plc

公司簡介
公司收入
產品
最近的發展

Sequent Scientific Ltd.

公司簡介
公司收入
產品
最近的發展

Zoetis Inc.

公司簡介
公司收入
產品
最近的發展

AdvaCare Pharma

公司簡介
公司收入
產品
最近的發展

Guangdong Tianbao Biological Pharmacy Co. Ltd.

公司簡介
公司收入
產品
最近的發展

Hanzhong Future Biotechnology Co. Ltd.

公司簡介
公司收入
產品
最近的發展

Hebei Huabang Biotechnology Co. Ltd.

公司簡介
公司收入
產品
最近的發展

Salius Pharma Pvt. Ltd.

公司簡介
公司收入
產品
最近的發展

Supharma Chem

公司簡介
公司收入
產品
最近的發展

Fredun Pharmaceuticals

公司簡介
公司收入
產品
最近的發展

註 - 在公司概況中，財務詳細資料和最新進展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR112114599

The global demand for Albendazole Veterinary Market is presumed to reach the market size of nearly USD 357.59 Million by 2032 from USD 190.78 Million in 2023 with a CAGR of 7.23% under the study period 2024-2050.

Albendazole is an anthelmintic medication used in veterinary medicine to treat parasitic worm infestations in animals, including livestock and pets. It is effective against various internal parasites, such as roundworms, tapeworms, and flukes. Administered orally, albendazole inhibits the parasites' energy metabolism, leading to their death. It is commonly used to improve animal health and productivity in farming and to treat pets. Veterinary use of albendazole must be carefully managed to prevent resistance and ensure food safety.

MARKET DYNAMICS

The widespread prevalence of parasitic infections in livestock and companion animals drives the albendazole veterinary market. To meet the growing demand for meat, milk, and other animal products, the increasing focus on improving animal health and productivity in the livestock sector significantly boosts market growth. Additionally, the rising awareness among pet owners about the health benefits of regular deworming and the prevention of zoonotic diseases drives the use of albendazole in companion animals. Government regulations and guidelines promoting the use of veterinary pharmaceuticals to ensure animal welfare and food safety further support albendazole veterinary market growth. Technological advancements in veterinary medicine, leading to the development of more efficient and user-friendly albendazole formulations, also contribute to increased adoption. The growing trend of preventive healthcare in veterinary practices, emphasizing regular parasite control, underscores the demand for effective anthelmintics like albendazole. Moreover, the expanding global livestock population and the intensification of farming practices necessitate the routine use of antiparasitic treatments, driving market growth. As the awareness and emphasis on animal health continue to rise, the demand for albendazole veterinary products is expected to remain strong, fostering market expansion. However, stringent regulatory approvals and the emergence of alternative treatments may challenge the market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Albendazole Veterinary. The growth and trends of Albendazole Veterinary industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Albendazole Veterinary market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Animal

Swine
Cattle
Others (Camel, etc.)

By Form

Tablets
Capsules
Others (Syrup, etc.)

By End-user

Veterinary Clinics
Veterinary Hospitals
Farms
Others (Research Institute, etc.)

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Albendazole Veterinary market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Albendazole Veterinary market include GSK Plc, Sequent Scientific Ltd., Zoetis Inc., AdvaCare Pharma, Guangdong Tianbao Biological Pharmacy Co. Ltd., Hanzhong Future Biotechnology Co. Ltd., Hebei Huabang Biotechnology Co. Ltd., Salius Pharma Pvt. Ltd., Supharma Chem, Fredun Pharmaceuticals. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. ALBENDAZOLE VETERINARY - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Animal
- 3.7.2 Market Attractiveness Analysis By Form
- 3.7.3 Market Attractiveness Analysis By End-user
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL ALBENDAZOLE VETERINARY MARKET ANALYSIS BY ANIMAL

5.1. Overview By Animal
5.2. Historical and Forecast Data
5.3. Analysis By Animal
5.4. Swine Historic and Forecast Sales By Regions
5.5. Cattle Historic and Forecast Sales By Regions
5.6. Others (Camel, etc.) Historic and Forecast Sales By Regions

6. GLOBAL ALBENDAZOLE VETERINARY MARKET ANALYSIS BY FORM

6.1. Overview By Form
6.2. Historical and Forecast Data
6.3. Analysis By Form
6.4. Tablets Historic and Forecast Sales By Regions
6.5. Capsules Historic and Forecast Sales By Regions
6.6. Others (Syrup, etc.) Historic and Forecast Sales By Regions

7. GLOBAL ALBENDAZOLE VETERINARY MARKET ANALYSIS BY END-USER

7.1. Overview By End-user
7.2. Historical and Forecast Data
7.3. Analysis By End-user
7.4. Veterinary Clinics Historic and Forecast Sales By Regions
7.5. Veterinary Hospitals Historic and Forecast Sales By Regions
7.6. Farms Historic and Forecast Sales By Regions
7.7. Others (Research Institute, etc.) Historic and Forecast Sales By Regions

8. GLOBAL ALBENDAZOLE VETERINARY MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE ALBENDAZOLE VETERINARY COMPANIES

9.1. Albendazole Veterinary Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF ALBENDAZOLE VETERINARY INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. GSK Plc
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Sequent Scientific Ltd.
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Zoetis Inc.
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. AdvaCare Pharma
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Guangdong Tianbao Biological Pharmacy Co. Ltd.
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Hanzhong Future Biotechnology Co. Ltd.
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Hebei Huabang Biotechnology Co. Ltd.
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Salius Pharma Pvt. Ltd.
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Supharma Chem
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. Fredun Pharmaceuticals
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments